Tiffany Olson
Direktor/Vorstandsmitglied bei MIMEDX GROUP, INC.
Vermögen: 2 Mio $ am 31.05.2024
Profil
Tiffany P.
Olson is currently serving as the Director at Biotel Research LLC.
She is also an Independent Director at Castle Biosciences, Inc., Director at Simon Youth Foundation, Director at Cardinal Health Foundation, Director at The Council on Radionuclides & Radiopharmaceuticals, Inc., Independent Non-Executive Director at Telix Pharmaceuticals Ltd., Director at Trusted Health Advisors LLC, Director at Education & Research Foundation For Nuclear Medicine & Mol, and Independent Director at MiMedx Group, Inc. In her former roles, Ms. Olson served as the Director at ThermoGenesis Holdings, Inc. from 2008 to 2010.
She was also the Director at Asuragen, Inc. from 2016 to 2021 and the Independent Director at BioTelemetry, Inc. from 2019 to 2021.
Additionally, she held positions as Director at Little Rapids Corp., Director at Community Health Network, Director at Ativa Medical Corp., Director at Exosome Diagnostics, Inc., Vice President-Diagnostics at Eli Lilly & Co. from 2009 to 2011, President, Chief Executive & Financial Officer at Roche Diagnostics Corp.
from 1997 to 2008, Owner at Resource Consulting Services, President at NaviMed LLC from 2011 to 2013, and President-Nuclear & Precision Health Solutions at Cardinal Health, Inc. from 2013 to 2021.
Ms. Olson obtained her undergraduate degree and MBA from St. Thomas University (Florida).
She also holds an undergraduate degree from the University of Minnesota.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
16.03.2023 | 95 235 ( 0,03% ) | 1 Mio $ | 31.05.2024 | |
CASTLE BIOSCIENCES, INC.
0,06% | 25.05.2024 | 16 403 ( 0,06% ) | 381 534 $ | 31.05.2024 |
MIMEDX GROUP, INC.
0,02% | 05.06.2024 | 28 988 ( 0,02% ) | 207 264 $ | 31.05.2024 |
Aktive Positionen von Tiffany Olson
Unternehmen | Position | Beginn |
---|---|---|
CASTLE BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 08.05.2021 |
TELIX PHARMACEUTICALS LIMITED | Direktor/Vorstandsmitglied | 31.03.2022 |
MIMEDX GROUP, INC. | Direktor/Vorstandsmitglied | 01.03.2024 |
Education & Research Foundation For Nuclear Medicine & Mol | Direktor/Vorstandsmitglied | 01.04.2022 |
The Council on Radionuclides & Radiopharmaceuticals, Inc. | Direktor/Vorstandsmitglied | - |
Cardinal Health Foundation | Direktor/Vorstandsmitglied | - |
Biotel Research LLC /Maryland/
Biotel Research LLC /Maryland/ Medical/Nursing ServicesHealth Services Cardiocore Lab LLC provides cardiac testing services The company was founded in 1992 and is headquartered in Bethesda, MD. | Direktor/Vorstandsmitglied | - |
Simon Youth Foundation | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Tiffany Olson
Unternehmen | Position | Ende |
---|---|---|
CARDINAL HEALTH, INC. | Corporate Officer/Principal | 01.10.2021 |
░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░ ░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Tiffany Olson
University of Minnesota | Undergraduate Degree |
St. Thomas University (Florida) | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
THERMOGENESIS HOLDINGS, INC. | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
CARDINAL HEALTH, INC. | Distribution Services |
CASTLE BIOSCIENCES, INC. | Health Technology |
MIMEDX GROUP, INC. | Health Technology |
Private Unternehmen | 15 |
---|---|
Roche Diagnostics Corp.
Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Health Technology |
Community Health Network
Community Health Network Medical/Nursing ServicesHealth Services Community Health Network provides mental health and social services. It offers clinical services such as anticoagulation, cardiology, diabetes education, general surgery, hematology oncology, obstetrics and gynecology, occupational medicine, wound clinic, diagnostic imaging, food and nutrition, laboratory, occupational health, ophthalmology, pain management, physical therapy, podiatry, rehabilitation, urology as well as ear, nose, and throat services. The company was founded in 1911 and is headquartered in Berlin, WI. | Health Services |
Simon Youth Foundation | |
Resource Consulting Services | |
Little Rapids Corp.
Little Rapids Corp. Medical SpecialtiesHealth Technology Little Rapids Corp. manufactures healthcare products. Its core product lines serve to the medical and paper industries. The company was founded by Charles N. Egan in 1947 and is headquartered in Green Bay, WI. | Health Technology |
Ativa Medical Corp.
Ativa Medical Corp. Medical SpecialtiesHealth Technology Ativa Medical Corp. provides medical diagnostic solutions. It offers analyzers that perform critical hematology and clinical chemistry tests; and disposable test cards for trauma, pediatric, oncology and geriatric patients. The company was founded by David W. Deetz in 2008 and is headquartered in St. Paul, MN. | Health Technology |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Health Services |
NaviMed LLC | |
Asuragen, Inc.
Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Health Technology |
BioTelemetry, Inc.
BioTelemetry, Inc. Medical SpecialtiesHealth Technology BioTelemetry, Inc. provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized core laboratory services for clinical research. The firm also develops proprietary integrated patient management platform that incorporates wireless data transmission network. It operates through the following segments: Healthcare, and Research. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials. The company was founded on April 22, 2013 and is headquartered in Malvern, PA. | Health Technology |
Biotel Research LLC /Maryland/
Biotel Research LLC /Maryland/ Medical/Nursing ServicesHealth Services Cardiocore Lab LLC provides cardiac testing services The company was founded in 1992 and is headquartered in Bethesda, MD. | Health Services |
Cardinal Health Foundation | |
The Council on Radionuclides & Radiopharmaceuticals, Inc. | |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals. The Product Development segment develops radiopharmaceutical products for commercialization. It focuses on cancer care, specifically in prostate, renal or kidney and glioblastoma or brain cancer. Its products include TLX250, TLX591, and TLX101. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in Melbourne, Australia. | Health Technology |
Education & Research Foundation For Nuclear Medicine & Mol |